FIGURE

Figure 1

ID
ZDB-FIG-231027-1
Publication
Murali Shankar et al., 2023 - Preclinical assessment of CAR-NK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer
Other Figures
All Figure Page
Back to All Figure Page
Figure 1

PD-L1.CAR NK-92 cells are highly cytotoxic against PD-L1+ targets in vitro. (A) Schematic representation of the PD-L1.CAR construct. A second-generation CAR under the spleen focus-forming virus (SFFV) promoter consists of PD-L1-specific scFv, CD8 hinge, CD28 transmembrane/costimulatory, and CD3ζ intracellular signaling domains. (B) Flow cytometric analysis of PD-L1.CAR expression on immunomagnetically enriched PD-L1.CAR NK-92 cells and parental NK-92 cells. PD-L1.CAR was detected using human recombinant PD-L1-Fc protein combined with anti-Fc secondary antibody. Filled gray areas indicate negative controls stained with secondary antibody only. (C) Flow cytometric analysis of PD-L1+ expression on the cell surface of MDA-MB-231 cells. Representative data from at least 3 independent experiments are shown. (D) Illustration of the NK cell and cancer cell model. NK-92 cells were lentivirally transduced with PD-L1.CAR, and the PD-L1+ metastatic breast adenocarcinoma cell line MDA-MB-231 was used as a target. Created with BioRender. (E) PD-L1.CAR NK-92 or parental NK-92 cells were co-cultured with MDA-MB-231 cells at E:T ratios of 1:1 and 10:1 for 2 hours as indicated and specific in vitro cytotoxicity was measured by Europium-based cytotoxicity assay. One-way ANOVA with Tukey’s multiple comparisons was used to calculate statistics. Data were pooled from 3 independent experiments, and means ± SEM are shown. **P<0.01; ****P<0.0001.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Front Immunol